Showing posts with label Lifestyle changes. Show all posts
Showing posts with label Lifestyle changes. Show all posts

Sunday, 27 February 2022

Contemporary Concepts of Schizophrenia | Chapter 15 | Issues and Developments in Medicine and Medical Research Vol.10

 Schizophrenia (SCZ) is a mental condition that hinders one's ability to reason, regulate emotions, make decisions, and communicate with others. It's a long-term medical problem. Schizophrenia can strike at any age, but it is more common in men's late teens to early twenties and women's late twenties to early thirties. SCZ is uncommon in children under the age of 12 and in those over the age of 40. With schizophrenia, it is possible to be cheerful. One of SCZ's defining characteristics is a lack of desire. Most symptoms of SCZ can be considerably reduced with therapy, as well as the risk of relapse. It's not a cure for SCZ, but it's a step in the right direction. To better understand the structure and function of the brain, experts look at genetics, behavioural studies, and modern imaging. SCZ treatment comprises medication, counselling, lifestyle changes, and social support, all of which lead to a better quality of life.

Author(s) Details:

J. Kavitha,
Department of Periodontia, Government Dental College and Hospital, Cuddalore District, Tamilnadu, India.

S. Sivakrishnan,
Department of Pharmacy, FEAT, Annamalai University, Annamalai Nagar, Tamilnadu, India.

Please see the link here: https://stm.bookpi.org/IDMMR-V10/article/view/5830

Friday, 12 June 2020

How to Reduce Cardiovascular Mortality and Morbidity in Population | Chapter 10 | Innovations in Medicine and Medical Research Vol. 3

Ischaemic heart disease and stroke are the world’s biggest killers. The good news is that 80% of cardiovascular diseases can be prevented with healthy lifestyle habits. The most effective approach to improve this situation is the reduction of risk factors levels. Small positive shifts of risk factors, across a whole population consistently leads to greater reductions in disease burden than the huge investment to the new drugs and devices including invasive procedures. Motivation is a key element of cardiovascular prevention. It means in practice non-smoking, support for nutrition changes, regular and effective physical activities and obesity management mainly.  As for nutrition how much people with high risk profile for Ischaemic heart disease and stroke know the role of saturated fatty acids and their recommended maximal daily intake (cca 30 g) ? How much from them monitor their content on food labels? But the decrease of their intake about to 10% of daily energetic intake leads to decline cardiovascular risk about 20-30%!. How much people know that adding 30 g unsalted nuts daily decreases cardiovascular risk about 30%?. The same accounts for increasing the fiber content. We present some concrete examples of daily menu and adequate proposals how to change to reach recommended values.  Regular and effective physical activities mean 150 to 300 min. of moderate-intensity exercise or 75 to 150 minutes of vigorous-intensity exercise each week for health benefits. This translates into an energy expenditure of 7.5 to 15 MET hours per week. That leads to a 31% reduction in all-cause mortality. The benefit concerns not cardiovascular diseases only but the metabolic and oncological protection too. Clinical evaluation, including exercise testing, should be considered for sedentary people with risk factors who intend to engage in vigorous physical activity. Specialized prevention programmes such as complex cardiovascular rehabilitation (including cardiotraining, education and cognitive-behavioural methods), home-based cardiac rehabilitation and yoga are very effective.  The nutrition and physical activity changes are two milestones of obesity management. The increase of BMI about 5kg/m2 leads to increase of mortality risk about 30% and about 40% risk of ischemic heart disease, stroke and other vascular diseases. Weight decrease in obese patients leads not only to reduction of these parameters, but moreover, to reduction of drug intake, hospitalisations and diagnostic and therapeutic procedures rate. It means significant economical benefit.

Author(s) Details
Štefan Farský,
House of the Heart (Dom Srdca), Slovak League against Hypertension, Martin, Slovakia.  

View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/178